Recently, a USP1 inhibitor was adapted to sensitize human cisplatin-resistant NSCLC cells 19, and it also destabilizes Snail expression and increases platinum sensitivity in ovarian cancer 15. The gene discussed is USP1; the disease is ovarian carcinoma.